Skip to main content

Advertisement

SpringerLink
Log in

Healthcare professionals’ perspectives and experiences of osteoporosis medication treatment: a qualitative systematic review

  • Review Article
  • Published:
Archives of Osteoporosis Aims and scope Submit manuscript

Abstract

Summary

This systematic review aimed to explore healthcare professionals’ (HCPs) experiences and perspectives of osteoporosis medication treatment through thematic synthesis of qualitative studies. We found themes about how osteoporosis is perceived as a disease, treatment decision-making and what empowers HCPs to provide the best possible care.

Purpose

The systematic review aimed to describe the perspectives and experiences of HCPs regarding osteoporosis medication treatment.

Methods

We performed searches in four electronic databases (Medline, Embase, PsycINFO and CINAHL) from database inception until May 2023 in any language. Data was analysed through inductive thematic synthesis.

Results

We included 27 primary studies that incorporated the views of 495 different HCPs. The following themes were identified: low-priority disease, challenges in treatment decision-making, minimising drug burden, conscious of communication barriers, fragmented care and advice, confidence through experience and collaboration.

Conclusions

HCPs were enthusiastic about optimising osteoporosis care through interprofessional collaboration and expertise, as well as educating and monitoring patients on treatment. They advocated for safety, comfort and reducing overall drug burden, especially in older patients with comorbidities. However, they had differences in opinions regarding who has responsibility for diagnosing and treating osteoporosis and struggled to provide the best possible care due to competing priorities, limited time and lack of adequate knowledge or evidence. The findings highlight the important and complementary role of different HCPs in osteoporosis treatment through a multidisciplinary model of care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Vijayakumar R, Büsselberg D (2016) Osteoporosis: an under-recognized public health problem. J Local Global Health Sci 2016(1). https://doi.org/10.5339/jlghs.2016.2

  2. Klibanski A, Adams-Campbell L, Bassford T, Blair SN, Boden SD, Ga D (2001) Osteoporosis prevention, diagnosis, and therapy. J Am Med Assoc 285(6):785–95

    Article  Google Scholar 

  3. Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ et al (2014) The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 25(5):1439–1443. https://doi.org/10.1007/s00198-014-2655-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Cooper A, Campion G, Melton LJ (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–9

    Article  CAS  PubMed  Google Scholar 

  5. Reid IR, Billington EO (2022) Drug therapy for osteoporosis in older adults. Lancet 399(10329):1080–1092. https://doi.org/10.1016/s0140-6736(21)02646-5

    Article  CAS  PubMed  Google Scholar 

  6. Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG et al (2017) Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res 32(3):424–430. https://doi.org/10.1002/jbmr.3074

    Article  PubMed  Google Scholar 

  7. Greenspan SL, Wyman A, Hooven FH, Adami S, Gehlbach S, Anderson FA Jr et al (2012) Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. J Am Geriatr Soc 60(3):455–461. https://doi.org/10.1111/j.1532-5415.2011.03854.x

    Article  PubMed  PubMed Central  Google Scholar 

  8. Netelenbos JC, Geusens PP, Ypma G, Buijs SJ (2011) Adherence and profile of non-persistence in patients treated for osteoporosis–a large-scale, long-term retrospective study in The Netherlands. Osteoporos Int 22(5):1537–1546. https://doi.org/10.1007/s00198-010-1372-5

    Article  CAS  PubMed  Google Scholar 

  9. Klop C, Welsing PM, Elders PJ, Overbeek JA, Souverein PC, Burden AM et al (2015) Long-term persistence with anti-osteoporosis drugs after fracture. Osteoporos Int 26(6):1831–1840. https://doi.org/10.1007/s00198-015-3084-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Fatoye F, Smith P, Gebrye T, Yeowell G (2019) Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open 9(4):e027049. https://doi.org/10.1136/bmjopen-2018-027049

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Cornelissen D, de Kunder S, Si L, Reginster JY, Evers S, Boonen A et al (2020) Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int 31(9):1645–1669. https://doi.org/10.1007/s00198-020-05378-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hiligsmann M, McGowan B, Bennett K, Barry M, Reginster JY (2012) The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland. Value Health 15(5):604–612. https://doi.org/10.1016/j.jval.2012.02.001

    Article  PubMed  Google Scholar 

  13. Lindsay BR, Olufade T, Bauer J, Babrowicz J, Hahn R (2016) Patient-reported barriers to osteoporosis therapy. Arch Osteoporos 11:19. https://doi.org/10.1007/s11657-016-0272-5

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chou L, Shamdasani P, Briggs A, Cicuttini F, Sullivan K, Seneviwickrama K et al (2017) Systematic scoping review of patients’ perceived needs of health services for osteoporosis. Osteoporos Int 28(11):3077–3098. https://doi.org/10.1007/s00198-017-4167-0

    Article  CAS  PubMed  Google Scholar 

  15. Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int 29(12):2623–2637. https://doi.org/10.1007/s00198-018-4759-3

    Article  CAS  PubMed  Google Scholar 

  16. Paskins Z, Crawford-Manning F, Cottrell E, Corp N, Wright J, Jinks C et al (2020) Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis. BMJ Open 10(11):e040634. https://doi.org/10.1136/bmjopen-2020-040634

    Article  PubMed  PubMed Central  Google Scholar 

  17. Naik-Panvelkar P, Norman S, Elgebaly Z, Elliott J, Pollack A, Thistlethwaite J et al (2020) Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice. BMC Fam Pract 21(1):32. https://doi.org/10.1186/s12875-020-01103-2

    Article  PubMed  PubMed Central  Google Scholar 

  18. Walsh ME, Fahey T, Moriarty F (2021) Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland. Arch Osteoporos 16(1):71. https://doi.org/10.1007/s11657-021-00932-7

    Article  PubMed  PubMed Central  Google Scholar 

  19. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

    Article  PubMed  PubMed Central  Google Scholar 

  20. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T et al (2012) A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73(5):691–705. https://doi.org/10.1111/j.1365-2125.2012.04167.x

    Article  PubMed  PubMed Central  Google Scholar 

  21. Braun V, Clarke V, Hayfield N, Terry G (2019) Thematic analysis Liamputtong editor. Singapore Springer Nature

  22. Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Quality Health 19(9):349–357

    Article  Google Scholar 

  23. Alami S, Hervouet L, Poiraudeau S, Briot K, Roux C (2016) Barriers to effective postmenopausal osteoporosis treatment: a qualitative study of patients’ and practitioners’ views. PLoS ONE 11(6):e0158365. https://doi.org/10.1371/journal.pone.0158365

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Bennett MJ, Center JR, Perry L (2023) Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study. Osteoporos Int 34(7):1249–1262. https://doi.org/10.1007/s00198-023-06748-0

    Article  PubMed  PubMed Central  Google Scholar 

  25. Brod M, Rousculp M, Cameron A (2008) Understanding compliance issues for daily self-injectable treatment in ambulatory care settings. Dove Med Press 2:129–136

    Google Scholar 

  26. Choi Y, Park H, Hong N, Rhee Y, Park W (2022) Qualitative focus group interview study of communication between patients, dentists and physicians for efficient osteonecrosis of the jaw practices. BMJ Open 12(3):e051054. https://doi.org/10.1136/bmjopen-2021-051054

    Article  PubMed  PubMed Central  Google Scholar 

  27. Claesson A, Toth-Pal E, Piispanen P, Salminen H (2015) District nurses’ perceptions of osteoporosis management: a qualitative study. Osteoporos Int 26(7):1911–1918. https://doi.org/10.1007/s00198-015-3086-1

    Article  CAS  PubMed  Google Scholar 

  28. Colon-Emeric CS, Hecker EJ, McConnell E, Herndon L, Little M, Xue T et al (2022) Improving shared decision-making for osteoporosis pharmacologic therapy in nursing homes: a qualitative analysis. Arch Osteoporos 17(1):11. https://doi.org/10.1007/s11657-021-01050-0

    Article  PubMed  PubMed Central  Google Scholar 

  29. Drew S, Judge A, Cooper C, Javaid MK, Farmer A, Gooberman-Hill R (2016) Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery. Osteoporos Int 27(5):1719–1727. https://doi.org/10.1007/s00198-015-3452-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Feldstein AC, Schneider J, Smith DH, Vollmer WM, Rix M, Glauber H et al (2008) Harnessing stakeholder perspectives to improve the care of osteoporosis after a fracture. Osteoporos Int 19(11):1527–1540. https://doi.org/10.1007/s00198-008-0605-3

    Article  CAS  PubMed  Google Scholar 

  31. Guzman-Clark JR, Fang MA, Sehl ME, Traylor L, Hahn TJ (2007) Barriers in the management of glucocorticoid-induced osteoporosis. Arthritis Rheum 57(1):140–146. https://doi.org/10.1002/art.22462

    Article  PubMed  Google Scholar 

  32. Hawarden A, Bullock L, Chew-Graham CA, Herron D, Hider S, Jinks C, et al. (2023) Incorporating FRAX into a nurse-delivered integrated care review: a multi-method qualitative study. BJGP Open 7(2). https://doi.org/10.3399/BJGPO.2022.0146

  33. Iversen MD, Vora RR, Servi A, Solomon DH (2011) Factors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providers. J Geriatr Phys Ther 34(2):72–81. https://doi.org/10.1097/JPT.0b013e3181ff03b4

    Article  PubMed  PubMed Central  Google Scholar 

  34. Jaakkola E (2007) Physicians’ views on the influence of patient participation on treatment decisions – an explorative study. Health Serv Manage Res 20:174–182

    Article  PubMed  Google Scholar 

  35. Jaglal S, Carroll J, Hawker G, McIsaac WJ, Jaakkimainen L, Cadarette SM et al (2003) How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Phys 49:462–468

    Google Scholar 

  36. Kaasalainen S, Papaioannou A, Burgess J, Van der Horst ML (2015) Exploring the nurse practitioner role in managing fractures in long-term care. Clin Nurs Res 24(6):567–588. https://doi.org/10.1177/1054773815577577

    Article  PubMed  PubMed Central  Google Scholar 

  37. Laird C, Williams KA, Benson H (2023) Perceptions and practices of aged care pharmacists regarding osteoporosis management: a qualitative study. Int J Clin Pharm. https://doi.org/10.1007/s11096-023-01586-w

    Article  PubMed  PubMed Central  Google Scholar 

  38. Lopez-Olivo MA, des Bordes JKA, Jibaja-Weiss M, Volk RJ, Suarez-Almazor ME (2022) Preferred strategies for delivering health information to patients with musculoskeletal disorders: a qualitative study. J Clin Rheumatol. 28(1):e102–e9. https://doi.org/10.1097/RHU.0000000000001627

    Article  PubMed  Google Scholar 

  39. Merle B, Haesebaert J, Bedouet A, Barraud L, Flori M, Schott AM et al (2019) Osteoporosis prevention: where are the barriers to improvement in French general practitioners? A qualitative study. PLoS ONE 14(7):e0219681. https://doi.org/10.1371/journal.pone.0219681

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Jah N, Pauline Siew Mei L, Chirk Jenn N, Emmerton L, Nik J, Lai PSM et al (2016) A qualitative study of community pharmacists’ opinions on the provision of osteoporosis disease state management services in Malaysia. BMC Health Serv Res 16:1–14. https://doi.org/10.1186/s12913-016-1686-x

    Article  Google Scholar 

  41. Otmar R, Reventlow SD, Nicholson GC, Kotowicz MA, Pasco JA (2012) General medical practitioners’ knowledge and beliefs about osteoporosis and its investigation and management. Arch Osteoporos 7:107–114. https://doi.org/10.1007/s11657-012-0088-x

    Article  PubMed  Google Scholar 

  42. Ravn Jakobsen P, Hermann AP, Soendergaard J, KockWiil U, Myhre Jensen C, Clemensen J (2021) The gap between women’s needs when diagnosed with asymptomatic osteoporosis and what is provided by the healthcare system: a qualitative study. Chronic Illn 17(1):3–16. https://doi.org/10.1177/1742395318815958

  43. Salminen H, Piispanen P, Toth-Pal E (2019) Primary care physicians’ views on osteoporosis management: a qualitative study. Arch Osteoporos 14(1):48. https://doi.org/10.1007/s11657-019-0599-9

    Article  PubMed  PubMed Central  Google Scholar 

  44. Sippli K, Rieger MA, Huettig F (2017) GPs’ and dentists’ experiences and expectations of interprofessional collaboration: findings from a qualitative study in Germany. BMC Health Serv Res 17(1):179. https://doi.org/10.1186/s12913-017-2116-4

    Article  PubMed  PubMed Central  Google Scholar 

  45. Sturrock A, Preshaw PM, Hayes C, Wilkes S (2017) Attitudes and perceptions of GPs and community pharmacists towards their role in the prevention of bisphosphonate-related osteonecrosis of the jaw: a qualitative study in the North East of England. BMJ Open 7(9):e016047. https://doi.org/10.1136/bmjopen-2017-016047

    Article  PubMed  PubMed Central  Google Scholar 

  46. Swart KMA, van Vilsteren M, van Hout W, Draak E, van der Zwaard BC, van der Horst HE et al (2018) Factors related to intentional non-initiation of bisphosphonate treatment in patients with a high fracture risk in primary care: a qualitative study. BMC Fam Pract 19(1):141. https://doi.org/10.1186/s12875-018-0828-0

    Article  PubMed  PubMed Central  Google Scholar 

  47. Tan EK, Loh KP, Goff SL (2017) Internal medicine hospitalists’ perceived barriers and recommendations for optimizing secondary prevention of osteoporotic hip fractures. South Med J. 110(12):749–53. https://doi.org/10.14423/SMJ.0000000000000735

    Article  PubMed  Google Scholar 

  48. Toh LS, Lai PSM, Othman S, Shah A, Dang CPL, Low BY et al (2018) Exploring the current and future role of the pharmacists in osteoporosis screening and management in Malaysia. Int J Clin Pharm 40(2):450–457. https://doi.org/10.1007/s11096-018-0597-9

    Article  CAS  PubMed  Google Scholar 

  49. Stowasser DA, Allinson YM, O’Leary M (2004) Understanding the medicines management pathway. J Pharm Pract Res 34(4):293–296. https://doi.org/10.1002/jppr2004344293

    Article  Google Scholar 

  50. Miki RA, Oetgen ME, Kirk J, Insogna KL, Lindskog DM (2008) Orthopaedic management improves the rate of early osteoporosis treatment after hip fracture. A randomized clinical trial. J Bone Joint Surg Am. 90(11):2346–53. https://doi.org/10.2106/JBJS.G.01246

    Article  PubMed  Google Scholar 

  51. Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15(10):767–778. https://doi.org/10.1007/s00198-004-1675-5

    Article  CAS  PubMed  Google Scholar 

  52. Tubre T, Collins J (2000) Jackson and Schuler (1985) Revisited: a meta-analysis of the relationships between role ambiguity, role conflict, and job performance. J Manag 26(1):155–169

    Google Scholar 

  53. Li W, Lin G, Xu A, Huang Y, Xi X (2020) Role ambiguity and role conflict and their influence on responsibility of clinical pharmacists in China. Int J Clin Pharm 42(3):879–886. https://doi.org/10.1007/s11096-020-01053-w

    Article  PubMed  Google Scholar 

  54. Tunc T, Kutanis RO (2009) Role conflict, role ambiguity, and burnout in nurses and physicians at a university hospital in Turkey. Nurs Health Sci 11(4):410–416. https://doi.org/10.1111/j.1442-2018.2009.00475.x

    Article  PubMed  Google Scholar 

  55. Dinsdale E, Hannigan A, O’Connor R, O’Doherty J, Glynn L, Casey M et al (2020) Communication between primary and secondary care: deficits and danger. Fam Pract 37(1):63–68. https://doi.org/10.1093/fampra/cmz037

    Article  PubMed  Google Scholar 

  56. Davis MM, Devoe M, Kansagara D, Nicolaidis C, Englander H (2012) “Did I do as best as the system would let me?” Healthcare professional views on hospital to home care transitions. J Gen Intern Med 27(12):1649–1656. https://doi.org/10.1007/s11606-012-2169-3

    Article  PubMed  PubMed Central  Google Scholar 

  57. Markiewicz O, Lavelle M, Lorencatto F, Judah G, Ashrafian H, Darzi A (2020) Threats to safe transitions from hospital to home: a consensus study in North West London primary care. Br J Gen Pract 70(690):e9–e19. https://doi.org/10.3399/bjgp19X707105

    Article  PubMed  Google Scholar 

  58. King BJ, Gilmore-Bykovskyi AL, Roiland RA, Polnaszek BE, Bowers BJ, Kind AJ (2013) The consequences of poor communication during transitions from hospital to skilled nursing facility: a qualitative study. J Am Geriatr Soc 61(7):1095–1102. https://doi.org/10.1111/jgs.12328

    Article  PubMed  Google Scholar 

  59. Sibounheuang P, Olson PS, Kittiboonyakun P (2020) Patients’ and healthcare providers’ perspectives on diabetes management: a systematic review of qualitative studies. Res Social Adm Pharm 16(7):854–874. https://doi.org/10.1016/j.sapharm.2019.09.001

    Article  PubMed  Google Scholar 

  60. Rushforth B, McCrorie C, Glidewell L, Midgley E, Foy R (2016) Barriers to effective management of type 2 diabetes in primary care: qualitative systematic review. Br J Gen Pract 66(643):e114–e127. https://doi.org/10.3399/bjgp16X683509

    Article  PubMed  PubMed Central  Google Scholar 

  61. Rai SK, Choi HK, Choi SHJ, Townsend AF, Shojania K, De Vera MA (2018) Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies. Rheumatology (Oxford) 57(7):1282–1292. https://doi.org/10.1093/rheumatology/kex530

    Article  PubMed  Google Scholar 

  62. (ANZBMS) AaNZBaMS. Position paper on secondary fracture prevention programs: a call to action [Available from: https://www.anzbms.org.au/downloads/ANZBMSPositionPaperonSecondaryFracturePreventionApril2015.pdf. Accessed Aug 2023

  63. Blain H, Masud T, Dargent-Molina P, Martin FC, Rosendahl E, van der Velde N et al (2016) A comprehensive fracture prevention strategy in older adults: the European Union Geriatric Medicine Society (EUGMS) statement. J Nutr Health Aging 20(6):647–652. https://doi.org/10.1007/s12603-016-0741-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE Jr, McLellan A et al (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27(10):2039–2046. https://doi.org/10.1002/jbmr.1698

    Article  PubMed  Google Scholar 

  65. Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD et al (2013) Capture the fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24(8):2135–2152. https://doi.org/10.1007/s00198-013-2348-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Barton DW, Piple AS, Smith CT, Moskal SA, Carmouche JJ (2021) The clinical impact of fracture liaison services: a systematic review. Geriatr Orthop Surg Rehabil 12:2151459320979978. https://doi.org/10.1177/2151459320979978

    Article  PubMed  PubMed Central  Google Scholar 

  67. Nayak S, Greenspan SL (2018) How can we improve osteoporosis care? A systematic review and meta-analysis of the efficacy of quality improvement strategies for osteoporosis. J Bone Miner Res 33(9):1585–1594. https://doi.org/10.1002/jbmr.3437

    Article  PubMed  Google Scholar 

  68. Wu CH, Tu ST, Chang YF, Chan DC, Chien JT, Lin CH et al (2018) Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone 111:92–100. https://doi.org/10.1016/j.bone.2018.03.018

    Article  PubMed  Google Scholar 

  69. Haider I, Naunton M, Davey R, Peterson GM, Baqir W, Kosari S (2021) How do pharmacists practice in aged care? A narrative review of models from Australia, England, and the United States of America. Int J Environ Res Public Health 18(23):12773. https://doi.org/10.3390/ijerph182312773

    Article  PubMed  PubMed Central  Google Scholar 

  70. Tan EC, Stewart K, Elliott RA, George J (2014) Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm 10(4):608–622. https://doi.org/10.1016/j.sapharm.2013.08.006

    Article  PubMed  Google Scholar 

  71. Montori VM, Shah ND, Pencille LJ, Branda ME, Van Houten HK, Swiglo BA et al (2011) Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J Med 124(6):549–556. https://doi.org/10.1016/j.amjmed.2011.01.013

    Article  PubMed  Google Scholar 

  72. Paskins Z, Torres Roldan VD, Hawarden AW, Bullock L, MeritxellUrtecho S, Torres GF et al (2020) Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan. Osteoporos Int 31(10):1837–1851. https://doi.org/10.1007/s00198-020-05479-w

    Article  CAS  PubMed  Google Scholar 

  73. Bowers BL, Drew AM, Verry C (2018) Impact of pharmacist-physician collaboration on osteoporosis treatment rates. Ann Pharmacother 52(9):876–883. https://doi.org/10.1177/1060028018770622

    Article  PubMed  PubMed Central  Google Scholar 

  74. Ailabouni N, Mangin D, Nishtala PS (2019) DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm 41(1):167–178. https://doi.org/10.1007/s11096-019-00784-9

    Article  PubMed  Google Scholar 

Download references

Funding

Fatima Rezae received Medical Research Future Fund scholarship provided by the Commonwealth Government of Australia for quality, safety and effectiveness of medicine use and medicine intervention by pharmacists. All other authors did not receive any funding for this research.

Author information

Authors and Affiliations

  1. School of Pharmacy, University of Sydney, Sydney, Australia

    Fatima Rezae, Rebekah Moles & Stephen Carter

  2. Rheumatology Department, Liverpool Hospital, Sydney, Australia

    Ayano Kelly

  3. Ingham Institute of Applied Medical Research, Sydney, Australia

    Ayano Kelly

  4. School of Health and Medicine, South Western Sydney Campus, University of New South Wales, Sydney, Australia

    Ayano Kelly

  5. School of Clinical Medicine, South Western Sydney Campus, University of New South Wales, Sydney, Australia

    Sagarika Dey

Authors
  1. Fatima Rezae
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayano Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sagarika Dey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rebekah Moles
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephen Carter
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Fatima Rezae was responsible for undertaking database searches, screening articles, assessing eligibility for inclusion, extracting and analysing data, assessing the comprehensiveness of reporting of included studies and writing the manuscript. Ayano Kelly contributed to the study design, data analysis and review of the manuscript. Sagarika Dey contributed to full-text screening, assessing the included studies for comprehensiveness of reporting and reviewing of the manuscript. Rebekah Moles assisted with the study design and data analysis. Stephen Carter contributed to the study design, data analysis and review of the manuscript.

Corresponding author

Correspondence to Fatima Rezae.

Ethics declarations

Conflicts of interest

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 812 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rezae, F., Kelly, A., Dey, S. et al. Healthcare professionals’ perspectives and experiences of osteoporosis medication treatment: a qualitative systematic review. Arch Osteoporos 19, 8 (2024). https://doi.org/10.1007/s11657-023-01359-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11657-023-01359-y

Keywords

Search

Navigation